Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
Harting
Mandy
M
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Vujevich
Justin
J
Goldberg
Leonard H
LH
D000287:Administration, Topical; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D006801:Humans; D000077271:Imiquimod; D018365:Neoplasm, Residual / Q000473:pathology*; D012535:Scalp / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D017211:Treatment Failure
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod